Escape from hsa-miR-519c enables drug-resistant cells to maintain high expression of ABCG2

Untitled work

Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714 · see citing works

The functions of animal microRNAs

Ambros, V. (2004) · Nature · doi:10.1038/nature02871 · Cited by 10,728 · see citing works

New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening

Skehan, P., Storeng, R., Scudiero, D. A., Monks, A. P., McMahon, J., Vistica, D. T., Warren, J. T., Bokesch, H. R., Kenney, S., & Boyd, M. R. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.13.1107 · Cited by 9,801 · see citing works

Non-coding RNAs and cancer: microRNAs and beyond

Raia, R. M., & Călin, G. A. (2011) · Journal of Nucleic Acids Investigation · doi:10.4081/jnai.2011.e5 · Cited by 3,394 · see citing works

A multidrug resistance transporter from human MCF-7 breast cancer cells

Doyle, L. A., Yang, W., Abruzzo, L. V., Krogmann, T. A., Gao, Y., Rishi, A. K., & Ross, D. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15665 · Cited by 2,319 · see citing works

Specificity of microRNA target selection in translational repressionPreprint

Doench, J. G., & Sharp, P. A. (2004) · Genes & Development · doi:10.1101/gad.1184404 · Cited by 1,642 · see citing works

The Widespread Impact of Mammalian MicroRNAs on mRNA Repression and Evolution

Farh, K. K.-H., Grimson, A., Jan, C., Lewis, B. P., Johnston, W. K., Lim, L. P., Burge, C. B., & Bartel, D. P. (2005) · Science · doi:10.1126/science.1121158 · Cited by 1,484 · see citing works

Proliferating Cells Express mRNAs with Shortened 3' Untranslated Regions and Fewer MicroRNA Target Sites

Sandberg, R., Neilson, J. R., Sarma, A., Sharp, P. A., & Burge, C. B. (2008) · Science · doi:10.1126/science.1155390 · Cited by 1,349 · see citing works

MicroRNA Expression Profiling in Human Ovarian Cancer: miR-214 Induces Cell Survival and Cisplatin Resistance by Targeting PTEN

Yang, H., Kong, W. W., He, L., Zhao, J., O’Donnell, J. D., Wang, J., Wenham, R. M., Coppola, D., Kruk, P. A., Nicosia, S. V., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2488 · Cited by 1,051 · see citing works

Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes.

Miyake, K., Mickley, L. A., Litman, T., Zhan, Z., Robey, R. W., Cristensen, B., Brangi, M., Greenberger, L., Dean, M. C., Fojo, T., et al. (1999) · PubMed · Cited by 819 · see citing works

The Role of ABC Transporters in Clinical Practice

Leonard, G. D., Fojo, T., & Bates, S. E. (2003) · The Oncologist · doi:10.1634/theoncologist.8-5-411 · Cited by 819 · see citing works

miRDB: A microRNA target prediction and functional annotation database with a wiki interface

Wang, X. (2008) · RNA · doi:10.1261/rna.965408 · Cited by 712 · see citing works

miR‐15b and miR‐16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells

Xia, L., Zhang, D., Du, R., Pan, Y., Zhao, L., Sun, S., Hong, L., Liu, J., & Fan, D. (2008) · International Journal of Cancer · doi:10.1002/ijc.23501 · Cited by 707 · see citing works

The Stem Cell Marker Bcrp/ABCG2 Enhances Hypoxic Cell Survival through Interactions with Heme

Krishnamurthy, P. C., Ross, D. D., Nakanishi, T., Bailey-Dell, K., Zhou, S., Mercer, K. E., Sarkadi, B., Sorrentino, B. P., & Schuetz, J. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313599200 · Cited by 661 · see citing works

Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin

Kovalchuk, O., Filkowski, J. N., Meservy, J. L., Ilnytskyy, Y., Tryndyak, V., Chekhun, V. F., & Pogribny, I. P. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0021 · Cited by 636 · see citing works

Overexpression of the BCRP/MXR/ABCP gene in a topotecan-selected ovarian tumor cell line.

Maliepaard, M., van Gastelen, M. A., de Jong, L. A., Pluim, D., van Waardenburg, R. C., Ruevekamp, M. C., Floot, B. G., & Schellens, J. H. M. (1999) · PubMed · Cited by 487 · see citing works

Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells

Hua Zhu, C., Wu, H., Liu, X., Evans, B. R., Medina, D. J., Liu, C., & Yang, J. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.06.007 · Cited by 457 · see citing works

Identification of Novel Isoforms of the EML4-ALK Transforming Gene in Non–Small Cell Lung Cancer

Choi, Y. L., Takeuchi, K., Soda, M., Inamura, K., Togashi, Y., Hatano, S., Enomoto, M., Hamada, T., Haruta, H., Watanabe, H., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6158 · Cited by 439 · see citing works

Improved targeting of miRNA with antisense oligonucleotides

Davis, S. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl183 · Cited by 422 · see citing works

A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance

Mishra, P. J., Humeniuk, R., Mishra, P. J., Longo-Sorbello, G. S. A., Banerjee, D., & Bertino, J. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706217104 · Cited by 417 · see citing works

MicroRNAs as Potential Agents to Alter Resistance to Cytotoxic Anticancer Therapy

Weidhaas, J. B., Babar, I., Nallur, S. M., Trang, P., Roush, S. F., Boehm, M., Gillespie, E. F., & Slack, F. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2858 · Cited by 388 · see citing works

MicroRNAs modulate the chemosensitivity of tumor cells

Blower, P. E., Chung, J.-H., Verducci, J. S., Lin, S., Park, J. K., Zunyan Dai, Y., Liu, C., Schmittgen, T. D., Reinhold, W. C., Croce, C. M., et al. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0573 · Cited by 364 · see citing works

Flavonoids Are Inhibitors of Breast Cancer Resistance Protein (ABCG2)-Mediated Transport

Zhang, S., Yang, X., & Morris, M. E. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.5.1208 · Cited by 359 · see citing works

Role of microRNAs in drug-resistant ovarian cancer cells

Sorrentino, A., Liu, C., Addario, A., Peschle, C., Scambia, G., & Ferlini, C. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.08.017 · Cited by 350 · see citing works

Pheophorbide a Is a Specific Probe for ABCG2 Function and Inhibition

Robey, R. W., Steadman, K., Polgár, O., Morisaki, K., Blayney, M., Mistry, P., & Bates, S. E. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3298 · Cited by 350 · see citing works

Overexpression of the ATP-binding cassette half-transporter, ABCG2 (Mxr/BCrp/ABCP1), in flavopiridol-resistant human breast cancer cells.

Robey, R. W., Medina-Pérez, W. Y., Nishiyama, K., Lahusen, T. J., Miyake, K., Litman, T., Senderowicz, A. M., Ross, D. D., & Bates, S. E. (2001) · PubMed · Cited by 341 · see citing works

MicroRNA-328 Negatively Regulates the Expression of Breast Cancer Resistance Protein (BCRP/ABCG2) in Human Cancer Cells

Pan, Y.-Z., Morris, M. E., & Yu, A. (2009) · Molecular Pharmacology · doi:10.1124/mol.108.054163 · Cited by 307 · see citing works

Reversal of a novel multidrug resistance mechanism in human colon carcinoma cells by fumitremorgin C.

Rabindran, S. K., He, H., Singh, M. S., Brown, E., Collins, K., Annable, T., & Greenberger, L. M. (1998) · PubMed · Cited by 305 · see citing works

Overexpression of wild-type breast cancer resistance protein mediates methotrexate resistance.

Volk, E. L., Farley, K. M., Wu, Y. F., Li, F., Robey, R. W., & Schneider, E. (2002) · PubMed · Cited by 248 · see citing works

Promoter characterization and genomic organization of the human breast cancer resistance protein (ATP-binding cassette transporter G2) gene

Bailey-Dell, K. J., Hassel, B. A., Doyle, L. A., & Ross, D. D. (2001) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(01)00270-6 · Cited by 225 · see citing works

ABCG2: structure, function and role in drug response

Polgár, O., Robey, R. W., & Bates, S. E. (2007) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.4.1.1 · Cited by 222 · see citing works

Identification of BCRP as transporter of benzo[ a ]pyrene conjugates metabolically formed in Caco-2 cells and its induction by Ah-receptor agonists

Ebert, B., Seidel, A., & Lampen, A. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi139 · Cited by 221 · see citing works

Identification of a Novel Estrogen Response Element in the Breast Cancer Resistance Protein ( ABCG2 ) Gene

Ee, P. L. R., Kamalakaran, S., Tonetti, D. A., He, X., Ross, D. D., & Beck, W. T. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3583 · Cited by 217 · see citing works

Peroxisome Proliferator-activated Receptor γ-regulated ABCG2 Expression Confers Cytoprotection to Human Dendritic Cells

Szatmári, I., Vámosi, G., Brázda, P., Bálint, B. L., Benkő, S., Széles, L., Jeney, V., Özvegy‐Laczka, C., Szántó, A., Barta, E., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604890200 · Cited by 180 · see citing works

P‐glycoprotein expression and schedule dependence of adriamycin cytotoxicity in human colon carcinoma cell lines

Lai, G., Chen, Y. N., Mickley, L. A., Fojo, A. T., & Bates, S. E. (1991) · International Journal of Cancer · doi:10.1002/ijc.2910490512 · Cited by 174 · see citing works

Regulation of ABCG2 Expression at the 3′ Untranslated Region of Its mRNA through Modulation of Transcript Stability and Protein Translation by a Putative MicroRNA in the S1 Colon Cancer Cell Line

To, K. K. W., Zhan, Z., Litman, T., & Bates, S. E. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00331-08 · Cited by 164 · see citing works

MRP3, BCRP, and P-Glycoprotein Activities are Prognostic Factors in Adult Acute Myeloid Leukemia

Benderra, Z., Faussat, A. M., Sayada, L., Perrot, J., Tang, R., Chaoui, D., Morjani, H., Marzac, C., Marie, J., & Legrand, O. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1895 · Cited by 154 · see citing works

MicroRNAs play a role in the development of human hematopoietic stem cells

Liao, R., Sun, J., Zhang, L., Lou, G., Chen, M., Zhou, D., Chen, Z., & Zhang, S. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21668 · Cited by 151 · see citing works

Epigenetic Modifiers: Basic Understanding and Clinical Development

Piekarz, R., & Bates, S. E. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2788 · Cited by 148 · see citing works

Histone Modifications at the ABCG2 Promoter following Treatment with Histone Deacetylase Inhibitor Mirror Those in Multidrug-Resistant Cells

To, K. K. W., Polgár, O., Huff, L. M., Morisaki, K., & Bates, S. E. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-0175 · Cited by 123 · see citing works

Aberrant Promoter Methylation of the ABCG2 Gene in Renal Carcinoma

To, K. K. W., Zhan, Z., & Bates, S. E. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00650-06 · Cited by 121 · see citing works

High level functional expression of the ABCG2 multidrug transporter in undifferentiated human embryonic stem cells

Apáti, Á., Orbán, T. I., Varga, N., Nemeth, A. H., Schamberger, A., Krízsik, V., Erdélyi‐Belle, B., Homolya, L., Várady, G., Padányi, R., et al. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.08.010 · Cited by 88 · see citing works

Novel 5′ Untranslated Region Variants of BCRP mRNA Are Differentially Expressed in Drug-Selected Cancer Cells and in Normal Human Tissues: Implications for Drug Resistance, Tissue-Specific Expression, and Alternative Promoter Usage

Nakanishi, T., Bailey-Dell, K. J., Hassel, B. A., Shiozawa, K., Sullivan, D. M., Turner, J. G., & Ross, D. D. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4572 · Cited by 70 · see citing works

Mutation-associated fusion cancer genes in solid tumors

Kaye, F. J. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0135 · Cited by 56 · see citing works

Identification of Compounds that Correlate with ABCG2 Transporter Function in the National Cancer Institute Anticancer Drug Screen

Deeken, J. F., Robey, R. W., Shukla, S., Steadman, K., Chakraborty, A. R., Balasubramanian, P., Schuetz, E. G., Holbeck, S. L., Ambudkar, S. V., & Bates, S. E. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.056192 · Cited by 29 · see citing works

Becatecarin (rebeccamycin analog, NSC 655649) is a transport substrate and induces expression of the ATP-binding cassette transporter, ABCG2, in lung carcinoma cells

Robey, R. W., Obrzut, T., Shukla, S., Polgár, O., Macalou, S., Bahr, J. C., Pietro, A. D., Ambudkar, S. V., & Bates, S. E. (2009) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0908-2 · Cited by 25 · see citing works

Allelic imbalance within the E-cadherin gene is an infrequent event in prostate carcinogenesis

Murant, S. J., Rolley, N., Phillips, S. M. A., Stower, M. J., & Maitland, N. J. (2000) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(200001)27:1 · Cited by 12 · see citing works

Role of the Breast Cancer Resistance Protein (BCRP/ABCG2) in Drug Transport—an Update

Mao, Q., & Unadkat, J. D. (2014) · The AAPS Journal · doi:10.1208/s12248-014-9668-6 · Cited by 676 · see citing works

Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance

Natarajan, K., Xie, Y., Baer, M. R., & Ross, D. D. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.01.002 · Cited by 408 · see citing works

Human ABCG2: structure, function, and its role in multidrug resistance.

Mo, W., & Zhang, J. (2012) · PubMed Central · Cited by 218 · see citing works

ID4 Imparts Chemoresistance and Cancer Stemness to Glioma Cells by Derepressing miR-9*–Mediated Suppression of SOX2

Jeon, H.-M., Sohn, Y.-W., Oh, S.-Y., Kim, S.-H., Beck, S. J., Kim, S., & Kim, H. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3340 · Cited by 204 · see citing works

MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside

To, K. K. W., Tong, C. W. S., Wu, M., & Cho, W. C. S. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i27.2949 · Cited by 195 · see citing works

Dysregulation of MicroRNAs in cancer

Chen, P., Su, J.-L., & Hung, M. (2012) · Journal of Biomedical Science · doi:10.1186/1423-0127-19-90 · Cited by 163 · see citing works

ATP-binding cassette efflux transporters and MDR in cancer

Pote, M. S., & Gacche, R. N. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103537 · Cited by 162 · see citing works

MicroRNA profiling in human diploid fibroblasts uncovers miR-519 role in replicative senescence

Marasa, B. S., Srikantan, S., Martindale, J. L., Kim, M. M., Lee, E. K., Gorospe, M., & Abdelmohsen, K. (2010) · Aging · doi:10.18632/aging.100159 · Cited by 132 · see citing works

Pharmacogenetics research on chemotherapy resistance in colorectal cancer over the last 20 years

Pańczyk, M. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i29.9775 · Cited by 122 · see citing works

The ABCG family of membrane‐associated transporters: you don't have to be big to be mighty

Kerr, I. D., Haider, A. J., & Gelissen, I. C. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01177.x · Cited by 122 · see citing works

MicroRNA pharmacogenomics: Post-transcriptional regulation of drug response

Rukov, J. L., & Shomron, N. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.04.003 · Cited by 124 · see citing works

Breast cancer resistance protein BCRP/ABCG2 regulatory microRNAs (hsa-miR-328, -519c and -520h) and their differential expression in stem-like ABCG2+ cancer cells

Li, X., Pan, Y.-Z., Seigel, G. M., Hu, Z.-H., Huang, M., & Yu, A. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.12.018 · Cited by 116 · see citing works

ABCG2 polymorphisms in gout: insights into disease susceptibility and treatment approaches

Cleophas, M. C. P., Joosten, L. A. B., Stamp, L. K., Dalbeth, N., Woodward, O. M., & Merriman, T. R. (2017) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s105854 · Cited by 114 · see citing works

MiR-181a enhances drug sensitivity in mitoxantone-resistant breast cancer cells by targeting breast cancer resistance protein (BCRP/ABCG2)

Jiao, X., Zhao, L., Ma, M., Bai, X., He, M., Yan, Y., Wang, Y., Chen, Q., Zhao, X., Zhou, M., et al. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2607-x · Cited by 103 · see citing works

Exploiting a novel miR-519c–HuR–ABCG2 regulatory pathway to overcome chemoresistance in colorectal cancer

To, K. K. W., Leung, W. W., & Ng, S. S. M. (2015) · Experimental Cell Research · doi:10.1016/j.yexcr.2015.09.011 · Cited by 99 · see citing works

ABC Transporters: Regulation and Association with Multidrug Resistance in Hepatocellular Carcinoma and Colorectal Carcinoma

Ceballos, M. P., Rigalli, J. P., Ceré, L. I., Semeniuk, M., Catania, V. A., & Ruiz, M. L. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180105103637 · Cited by 95 · see citing works

Micro RNA s and their relevance to ABC transporters

Haenisch, S., Werk, A. N., & Cascorbi, I. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12251 · Cited by 94 · see citing works

Proinflammatory Cytokines Enhance Estrogen-dependent Expression of the Multidrug Transporter Gene ABCG2 through Estrogen Receptor and NFκB Cooperativity at Adjacent Response Elements

Pradhan, M., Bembinster, L. A., Baumgarten, S. C., & Frasor, J. M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.155309 · Cited by 92 · see citing works

Chemotherapy-induced modification of microRNA expression in esophageal cancer

Hummel, R. (2011) · Oncology Reports · doi:10.3892/or.2011.1381 · Cited by 91 · see citing works

3’UTR Shortening Potentiates MicroRNA-Based Repression of Pro-differentiation Genes in Proliferating Human Cells

Hoffman, Y., Bublik, D. R., P. Ugalde, A., Elkon, R., Biniashvili, T., Agami, R., Oren, M., & Pilpel, Y. (2016) · PLOS Genetics · doi:10.1371/journal.pgen.1005879 · Cited by 90 · see citing works

microRNAs Make the Call in Cancer Personalized Medicine

Detassis, S., Grasso, M., Vescovo, V. D., & Denti, M. A. (2017) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2017.00086 · Cited by 88 · see citing works

In Vitro and In Vivo Evidence for the Importance of Breast Cancer Resistance Protein Transporters (BCRP/MXR/ABCP/ABCG2)

zu Schwabedissen, H. E. M., & Kroemer, H. K. (2010) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-14541-4_9 · Cited by 89 · see citing works

MicroRNA profiling in K-562 cells under imatinib treatment

Turrini, E., Haenisch, S., Lächelt, S., Diewock, T., Bruhn, O., & Cascorbi, I. (2012) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e328350012b · Cited by 82 · see citing works

Potential Role of Epigenetic Mechanisms in the Regulation of Drug Metabolism and Transport

Ingelman‐Sundberg, M., Zhong, X., Hankinson, O., Beedanagari, S. R., Yu, A., Peng, L., & Osawa, Y. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.053157 · Cited by 82 · see citing works

Redox-responsive nanoplatform for codelivery of miR-519c and gemcitabine for pancreatic cancer therapy

Xin, X., Kumar, V., Lin, F., Kumar, V., Bhattarai, R. S., Bhatt, V. R., Tan, C., & Mahato, R. I. (2020) · Science Advances · doi:10.1126/sciadv.abd6764 · Cited by 80 · see citing works

MicroRNA: a prognostic biomarker and a possible druggable target for circumventing multidrug resistance in cancer chemotherapy

To, K. K. W. (2013) · Journal of Biomedical Science · doi:10.1186/1423-0127-20-99 · Cited by 78 · see citing works

MicroRNA Pharmacoepigenetics: Posttranscriptional Regulation Mechanisms behind Variable Drug Disposition and Strategy to Develop More Effective Therapy

Yu, A., Tian, Y., Tu, M., Ho, P. Y., & Jilek, J. L. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.067470 · Cited by 79 · see citing works

The dark side of a success story: microRNAs of the C19MC cluster in human tumours

Flor, I., & Bullerdiek, J. (2012) · The Journal of Pathology · doi:10.1002/path.4014 · Cited by 75 · see citing works

The Challenge of Exploiting ABCG2 in the Clinic

Robey, R. W., Ieranò, C., Zhan, Z., & Bates, S. E. (2011) · Current Pharmaceutical Biotechnology · doi:10.2174/138920111795163913 · Cited by 73 · see citing works

Structure and function of BCRP, a broad specificity transporter of xenobiotics and endobiotics

Jani, M., Temesszentandrási‐Ambrus, C., Magnan, R., Jakab, K. T., Beéry, E., Zolnerciks, J. K., & Krajcsi, P. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1224-8 · Cited by 74 · see citing works

Noncoding microRNAs: small RNAs play a big role in regulation of ADME?

Yu, A., & Pan, Y. (2012) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2012.02.011 · Cited by 69 · see citing works

miRNAs as Mediators of Drug Resistance

Haenisch, S., & Cascorbi, I. (2012) · Epigenomics · doi:10.2217/epi.12.39 · Cited by 67 · see citing works

miR‐495 Enhances the Sensitivity of Non‐Small Cell Lung Cancer Cells to Platinum by Modulation of Copper‐Transporting P‐type Adenosine Triphosphatase A (ATP7A)

Song, L., Li, Y., Li, W., Wu, S., & Li, Z. (2013) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24665 · Cited by 67 · see citing works

Emerging Roles of RNA 3′-end Cleavage and Polyadenylation in Pathogenesis, Diagnosis and Therapy of Human Disorders

Nourse, J. P., Spada, S., & Danckwardt, S. (2020) · Biomolecules · doi:10.3390/biom10060915 · Cited by 64 · see citing works

Post‐transcriptional regulation of the tumor suppressor miR‐139‐5p and a network of miR‐139‐5p‐mediated m RNA interactions in colorectal cancer

Shen, K., Mao, R., Ma, L., Li, Y., Qiu, Y., Cui, D., Le, V., Yin, P., Ni, L., & Liu, J. (2014) · FEBS Journal · doi:10.1111/febs.12880 · Cited by 61 · see citing works

Downregulation of MicroRNA miR-520h by E1A Contributes to Anticancer Activity

Su, J.-L., Chen, P. B., Chen, Y.-H., Chen, S., Chang, Y.-W., Jan, Y., Cheng, X., Hsiao, M., & Hung, M. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4148 · Cited by 60 · see citing works

The ABCG2/BCRP transporter and its variants – from structure to pathology

Sarkadi, B., Homolya, L., & Hegedűs, T. (2020) · FEBS Letters · doi:10.1002/1873-3468.13947 · Cited by 61 · see citing works

ATP-binding cassette transmembrane transporters and their epigenetic control in cancer: an overview

Arrigoni, E., Galimberti, S., Petrini, M., Danesi, R., & Paolo, A. D. (2016) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2016.1215423 · Cited by 60 · see citing works

Contribution of microRNAs to radio- and chemoresistance of brain tumors and their therapeutic potential

Chistiakov, D. A., & Chekhonin, V. P. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.03.031 · Cited by 58 · see citing works

Hematopoietic stem cells exhibit a specific ABC transporter gene expression profile clearly distinct from other stem cells

Tang, L., Bergevoet, S. M., Gilissen, C., de Witte, T., Jansen, J. H., van der Reijden, B. A., & Raymakers, R. A. P. (2010) · BMC Pharmacology · doi:10.1186/1471-2210-10-12 · Cited by 58 · see citing works

The ABCG2 transporter and its relations with the pharmacokinetics, drug interaction and lipid-lowering effects of statins

Hu, M., To, K. K. W., Mak, V. W. L., & Tomlinson, B. (2010) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2011.538383 · Cited by 58 · see citing works

miR-520h is crucial for DAPK2 regulation and breast cancer progression

Su, C.-M., Wang, M.-Y., Hong, C.-C., Chen, H.-A., Su, Y.-H., Wu, C.-H., Huang, M.-T., Chang, Y.-W., Jiang, S.-S., Sung, S.-Y., et al. (2015) · Oncogene · doi:10.1038/onc.2015.168 · Cited by 55 · see citing works

The Roles of microRNAs in Cancer Multidrug Resistance

Pavlíková, L., Šereš, M., Breier, A., & Sulová, Z. (2022) · Cancers · doi:10.3390/cancers14041090 · Cited by 54 · see citing works

Single Nucleotide Polymorphisms in MicroRNA Binding Sites of Oncogenes: Implications in Cancer and Pharmacogenomics

Manikandan, M., & Munirajan, A. K. (2013) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2013.0098 · Cited by 52 · see citing works

microRNAs: a role in drug resistance in parasitic nematodes?

Devaney, E., Winter, A. D., & Britton, C. (2010) · Trends in Parasitology · doi:10.1016/j.pt.2010.05.003 · Cited by 51 · see citing works

Characterization of the breast cancer resistance protein (BCRP/ABCG2) in clear cell renal cell carcinoma

Reustle, A., Fisel, P., Renner, O., Büttner, F., Winter, S., Rausch, S., Kruck, S., Nies, A. T., Hennenlotter, J., Scharpf, M. O., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31741 · Cited by 50 · see citing works

Improving the Intracellular Drug Concentration in Lung Cancer Treatment through the Codelivery of Doxorubicin and miR-519c Mediated by Porous PLGA Microparticle

Wu, D., Wang, C., Yang, J., Wang, H., Han, H., Zhang, A., Yang, Y., & Li, Q. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00702 · Cited by 45 · see citing works

microRNAs with different functions and roles in disease development and as potential biomarkers of diabetes: progress and challenges

Seyhan, A. A. (2015) · Molecular BioSystems · doi:10.1039/c5mb00064e · Cited by 43 · see citing works

Utilizing non-coding RNA-mediated regulation of ATP binding cassette (ABC) transporters to overcome multidrug resistance to cancer chemotherapy

To, K. K. W., Huang, Z., Zhang, H., Ashby, C. R., & Fu, L. (2024) · Drug Resistance Updates · doi:10.1016/j.drup.2024.101058 · Cited by 43 · see citing works

Nucleolin-Targeting AS1411 Aptamer-Modified Micelle for the Co-Delivery of Doxorubicin and miR-519c to Improve the Therapeutic Efficacy in Hepatocellular Carcinoma Treatment

Liang, X., Wang, Y., Shi, H., Dong, M., Han, H., & Li, Q. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s304526 · Cited by 41 · see citing works

ABCC4 is regulated by microRNA-124a and microRNA-506

Markova, S. M., & Kroetz, D. L. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.10.017 · Cited by 42 · see citing works

Alternative polyadenylation: An enigma of transcript length variation in health and disease

Mohanan, N. K., Shaji, F., Koshre, G. R., & Laishram, R. S. (2021) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1692 · Cited by 41 · see citing works

Transcription Factors Sp1 and Sp3 Regulate Expression of Human ABCG2 Gene and Chemoresistance Phenotype

Yang, W., Song, M.-J., Park, E. Y., Lee, J.-J., Park, J., Park, K., Park, J. H., & Kim, H. (2013) · Molecules and Cells · doi:10.1007/s10059-013-0191-x · Cited by 40 · see citing works

Expression profile of MicroRNA: An Emerging Hallmark of Cancer

Zaheer, U., Faheem, M., Qadri, I., Begum, N., Yassine, H. M., Thani, A. A. A., & Mathew, S. (2019) · Current Pharmaceutical Design · doi:10.2174/1386207322666190325122821 · Cited by 39 · see citing works

Transcription factor-mediated regulation of the BCRP/ ABCG2 efflux transporter: a review across tissues and species

Gorczyca, L., & Aleksunes, L. M. (2020) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2020.1732348 · Cited by 39 · see citing works

MicroRNAs and drug resistance of breast cancer: basic evidence and clinical applications

Tian, W., Chen, J., He, H., & Deng, Y. (2012) · Clinical & Translational Oncology · doi:10.1007/s12094-012-0929-5 · Cited by 38 · see citing works

MicroRNAs as potential therapeutic targets to predict responses to oxaliplatin in colorectal cancer: From basic evidence to therapeutic implication

Marjaneh, R. M., Khazaei, M., Ferns, G. A., Avan, A., & Aghaee‐Bakhtiari, S. H. (2019) · IUBMB Life · doi:10.1002/iub.2108 · Cited by 38 · see citing works

Role of 3’-untranslated region translational control in cancer development, diagnostics and treatment

Vislovukh, A. A. (2014) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v5.i1.40 · Cited by 38 · see citing works

Regulation and Expression of the ATP-Binding Cassette Transporter ABCG2 in Human Embryonic Stem Cells

Padmanabhan, R., Chen, K. G., Gillet, J., Handley, M. D., Mallon, B. S., Hamilton, R. S., Park, K., Varma, S., Mehaffey, M. G., Robey, P. G., et al. (2012) · Stem Cells · doi:10.1002/stem.1195 · Cited by 37 · see citing works

An update on efflux and uptake transporters as determinants of statin response

Rocha, K. C. E., Pereira, B. M. V., & Rodrigues, A. C. (2018) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2018.1482276 · Cited by 37 · see citing works

ABCG2 regulates the pattern of self-renewing divisions in cisplatin-resistant non-small cell lung cancer cell lines

Tang, Y. C., Hou, J., Li, G., Song, Z., Li, X., Cui, Y., Liu, W., Hu, Y., & Xu, Y. (2014) · Oncology Reports · doi:10.3892/or.2014.3470 · Cited by 37 · see citing works

PharmGKB summary

Fohner, A. E., Brackman, D. J., Giacomini, K. M., Altman, R. B., & Klein, T. E. (2017) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0000000000000305 · Cited by 36 · see citing works

The miRNA–Drug Resistance Connection: A New Era of Personalized Medicine Using Noncoding RNA Begins

Mishra, P. J. (2012) · Pharmacogenomics · doi:10.2217/pgs.12.121 · Cited by 35 · see citing works

The C421A (Q141K) polymorphism enhances the 3′-untranslated region (3′-UTR)-dependent regulation of ATP-binding cassette transporter ABCG2

Ripperger, A., & Benndorf, R. A. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.02.011 · Cited by 34 · see citing works

The effects of micro RNA on the absorption, distribution, metabolism and excretion of drugs

He, Y., Chevillet, J. R., Liu, G., Kim, T. K., & Wang, K. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12968 · Cited by 33 · see citing works

Epigenetic regulation of drug processing genes

Klaassen, C. D., Lü, H., & Cui, J. Y. (2011) · Toxicology Mechanisms and Methods · doi:10.3109/15376516.2011.562758 · Cited by 31 · see citing works

Mechanisms of genetic regulation in gene expression: examples from drug metabolizing enzymes and transporters

Glubb, D. M., & Innocenti, F. (2010) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.125 · Cited by 29 · see citing works

Tissue microRNAs as predictive markers for gastric cancer patients undergoing palliative chemotherapy

Smid, D. M., Kulda, V., Srbecká, K., Kubačková, D., Doležal, J., Daum, O., Kučera, R., Topolčan, O., Třeška, V., Skalický, T., et al. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3484 · Cited by 26 · see citing works

Role of microRNAs in mechanisms of glioblastoma resistance to radio- and chemotherapy

Koshkin, P. A., Chistiakov, D. A., & Chekhonin, V. P. (2013) · Biochemistry (Moscow) · doi:10.1134/s0006297913040019 · Cited by 25 · see citing works

miRNAs for the Detection of MultiDrug Resistance: Overview and Perspectives

Gisel, A., Valvano, M., Idrissi, I. G. E., Nardulli, P., Azzariti, A., Carrieri, A., Contino, M., & Colabufo, N. A. (2014) · Molecules · doi:10.3390/molecules19055611 · Cited by 23 · see citing works

Alternative Polyadenylation of ABC Transporters of the C-Family (ABCC1, ABCC2, ABCC3) and Implications on Posttranscriptional Micro-RNA Regulation

Bruhn, O., Lindsay, M., Wiebel, F., Kaehler, M., Nagel, I., Böhm, R., Röder, C., & Cascorbi, I. (2019) · Molecular Pharmacology · doi:10.1124/mol.119.116590 · Cited by 22 · see citing works

Efflux ABC transporters in drug disposition and their posttranscriptional gene regulation by microRNAs

Wang, Y., Tu, M.-J., & Yu, A.-M. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1423416 · Cited by 21 · see citing works

Length variants of the ABCB1 3′-UTR and loss of Mirna Binding Sites: Possible Consequences in Regulation and Pharmacotherapy Resistance

Bruhn, O., Drerup, K. A., Kaehler, M., Haenisch, S., Röder, C., & Cascorbi, I. (2016) · Pharmacogenomics · doi:10.2217/pgs.15.175 · Cited by 19 · see citing works

Precision-engineered reporter cell lines reveal ABCG2 regulation in live lung cancer cells

Kovacsics, D., Brózik, A., Tihanyi, B., Matula, Z., Borsy, A., Mészáros, N., Szabó, E., Németh, E., Fóthi, Á., Zámbó, B., et al. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.113865 · Cited by 17 · see citing works

Side Population

Behbod, F., & Vivanco, M. D. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2519-3_4 · Cited by 16 · see citing works

ABCG2 in Acute Myeloid Leukemia: Old and New Perspectives

Damiani, D., & Tiribelli, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087147 · Cited by 15 · see citing works

Role of Breast Cancer Resistance Protein (BCRP, ABCG2) in Cancer Outcomes and Drug Resistance

Natarajan, K., Baer, M. R., & Ross, D. D. (2014) · Resistance to targeted anti-cancer therapeutics · doi:10.1007/978-3-319-09801-2_3 · Cited by 13 · see citing works

MiRNAs: main players of cancer drug resistance target ABC transporters

Mohammadi, F., Nejatollahi, M., Sheikhnia, F., Ebrahimi, Y., Mohammadi, M., Rashidi, V., Alizadeh‐Fanalou, S., Azizzadeh, B., & Majidinia, M. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03719-y · Cited by 12 · see citing works

Modulation of Expression and Activity of ABC Transporters by the Phytoestrogen Genistein. Impact on Drug Disposition

Rigalli, J. P., Ciriaci, N., Mottino, A. D., Catania, V. A., & Ruiz, M. L. (2016) · Current Medicinal Chemistry · doi:10.2174/0929867323666160406120711 · Cited by 11 · see citing works

Drug transporters in the development of multidrug resistance in colorectal cancer

To, K. K. W., Wu, M., Tong, C. W. S., & Yan, W. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819937-4.00002-9 · Cited by 10 · see citing works

Regulation of drug transporters by microRNA and implications in disease treatment

Chae, Y., Chang, J., Lee, M.-K., Lim, J., Shin, K., & Lee, K. (2021) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-021-00538-8 · Cited by 10 · see citing works

miR-9a mediates the role of Lethal giant larvae as an epithelial growth inhibitor in Drosophila

Daniel, S. G., Russ, A. D., Guthridge, K. M., Raina, A., Estes, P. S., Parsons, L. M., Richardson, H. E., Schroeder, J. A., & Zarnescu, D. C. (2017) · Biology Open · doi:10.1242/bio.027391 · Cited by 8 · see citing works

Lost in Translation: Regulation of ABCG2 Expression in Human Embryonic Stem Cells

Padmanabhan, R. (2014) · Journal of Stem Cell Research & Therapy · doi:10.4172/2157-7633.1000180 · Cited by 7 · see citing works

The importance of drug transporters in human pluripotent stem cells and in early tissue differentiation

Apáti, Á., Szebényi, K., Erdei, Z., Várady, G., Orbán, T. I., & Sarkadi, B. (2015) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2016.1121382 · Cited by 7 · see citing works

Noncoding RNAs in Therapeutic Resistance of Cancer

Jia, L., & Yang, A. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-1498-7_10 · Cited by 6 · see citing works

A Novel Biomarker Based on miRNA to Predict the Prognosis of Muscle-Invasive Bladder Urothelial Carcinoma

Feng, Y., Feng, Q., Xu, L., Jiang, Y., Fang, M., & Shu, X. (2019) · Journal of Oncology · doi:10.1155/2019/2654296 · Cited by 6 · see citing works

MiR-548c-3p through suppressing Tyms and Abcg2 increases the sensitivity of colorectal cancer cells to 5-fluorouracil

Khalili, E., Afgar, A., Rajabpour, A., Aghaee‐Bakhtiari, S. H., Jamialahmadi, K., & Teimoori‐Toolabi, L. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e21775 · Cited by 5 · see citing works

Membrane transporters and transporter substrates as biomarkers for drug pharmacokinetics, pharmacodynamics, and toxicity/adverse events

Tóth, B., Krajcsi, P., & Magnan, R. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-404630-6.00056-7 · Cited by 5 · see citing works

Role of MicroRNAs in Anti-cancer Drug Resistance

Wiemer, E. A. C. (2010) · Springer eBooks · doi:10.1007/978-94-007-0298-1_19 · Cited by 5 · see citing works

A Systematic Review of Clinical Validated and Potential miRNA Markers Related to the Efficacy of Fluoropyrimidine Drugs

Sun, X., Chen, J., Chen, X., Gao, Q., Chen, W., Zou, X., Zhang, F., Gao, S., Qiu, S., Yue, X., et al. (2022) · Disease Markers · doi:10.1155/2022/1360954 · Cited by 4 · see citing works

Recent Advances in Novel Recombinant RNAs for Studying Post-transcriptional Gene Regulation in Drug Metabolism and Disposition

Tu, M., & Yu, A. (2023) · Current Drug Metabolism · doi:10.2174/1389200224666230425232433 · Cited by 4 · see citing works

MicroRNAs in Cancer Drug Resistance and Drug Sensitivity

Seca, H., Lima, R. T., & Vasconcelos, M. H. (2014) · Springer eBooks · doi:10.1007/978-3-319-03725-7_11 · Cited by 4 · see citing works

Breast Cancer Resistance Protein (BCRP) or ABCG2

Basseville, A., Robey, R. W., Bahr, J. C., & Bates, S. E. (2014) · doi:10.1002/9781118705308.ch11 · Cited by 4 · see citing works

Multidrug Resistance Transporters – Roles in maintaining Cancer Stem-Like Cells

Tø, Kenneth, K. W., & Fu, L. W. (2011) · InTech eBooks · doi:10.5772/23867 · Cited by 3 · see citing works

The 3′ UTR Landscape in Cancer

Schmidt, R., Ghosh, S., & Zavolan, M. (2018) · Wiley eBooks · doi:10.1002/9780470015902.a0027958 · Cited by 3 · see citing works

MicroRNAs in Predicting Radiotherapy and Chemotherapy Response

Noonan, E. J., Place, R. F., & Li, L. (2010) · Springer eBooks · doi:10.1007/978-94-007-0298-1_18 · Cited by 2 · see citing works

ABCG2, THE BREAST CANCER RESISTANCE PROTEIN (BCRP)

Robey, R. W., Lusvarghi, S., Chau, C. H., Basseville, A., Figg, W. D., Ambudkar, S. V., & Bates, S. E. (2022) · doi:10.1002/9781119739883.ch12 · Cited by 2 · see citing works

A Brief Outlook on Pharmacogenetics (PGx): Focus in MicroRNAs (miRNAs) and Cancer Stem Cells (CSCs)

Sandra, F. (2019) · Indonesian Journal of Cancer Chemoprevention · doi:10.14499/indonesianjcanchemoprev10iss1pp46-50 · Cited by 1 · see citing works

MicroRNA implication in therapeutic resistance and metastatic dissemination of bone-associated tumors

Rodriguez, L., Jacques, C., & Ory, B. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-416721-6.00015-7 · Cited by 1 · see citing works

CONTRIBUTIONS OF TM5, ECL3 AND TM6 OF HUMAN BCRP TO ITS OLIGOMERIZATION ACTIVITIES AND TRANSPORT FUNCTIONS

Mo, W. (2012) · IUScholarWorks (Indiana University) · doi:10.7912/c2/293

Breast cancer resistance protein BCRP/ABCG2 regulatory microRNAs (hsa-miR-328, -519c and -520h) and their differential expression in stem-like ABCG2+ cancer cells

Li, X., Pan, Y.-Z., Seigel, G. M., Hu, Z.-H., Huang, M., & Yu, A. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.12.018 · Cited by 116 · see citing works

Abstract 791: The predictive value of a novel miR-519c-HuR-ABCG2 regulatory pathway in chemoresistance of colorectal cancer

To, K. K. W., Leung, W. W., & Ng, S. S. M. (2012) · Cancer Research · doi:10.1158/1538-7445.am2012-791 · Cited by 1 · see citing works

Role of MicroRNAs in Anti-cancer Drug Resistance

Wiemer, E. A. C. (2010) · Springer eBooks · doi:10.1007/978-94-007-0298-1_19 · Cited by 5 · see citing works

Exploiting a novel miR-519c–HuR–ABCG2 regulatory pathway to overcome chemoresistance in colorectal cancer

To, K. K. W., Leung, W. W., & Ng, S. S. M. (2015) · Experimental Cell Research · doi:10.1016/j.yexcr.2015.09.011 · Cited by 99 · see citing works

Regulation of breast cancer resistance protein (BCRP/ABCG2) by microRNA‐328

Pan, Y., Morris, M. E., & Yu, A. (2010) · The FASEB Journal · doi:10.1096/fasebj.24.1_supplement.964.14